Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 29, 2025, 180 Life Sciences (ATNF) has a market cap of $3.896 million USD. According to our data, 180 Life Sciences is ranked No.9076 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 29, 2025 | $3.90 M |
-32.62%
|
| Dec 31, 2024 | $5.78 M |
-55.24%
|
| Dec 29, 2023 | $12.92 M |
-93.69%
|
| Dec 30, 2022 | $0.20 B |
-95.65%
|
| Dec 31, 2021 | $4.71 B |
42.86%
|
| Dec 31, 2020 | $3.30 B |
-74.47%
|
| Dec 31, 2019 | $12.91 B |
4.84%
|
| Dec 31, 2018 | $12.31 B |
5.05%
|
| Dec 29, 2017 | $11.72 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 AbbVie
ABBV
|
$342.32 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$152.20 B |
0.126 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
USA
|
 Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
USA
|
 Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
USA
|
 Pfizer
PFE
|
$130.73 B |
-0.001 M
|
USA
|
 Merck
MRK
|
$212.01 B |
-0.001 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
USA
|
 Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
USA
|
 Novo Nordisk
NVO
|
$290.79 B |
71.582 B
|
Denmark
|
 Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
USA
|
 Illumina
ILMN
|
$12.20 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$12.13 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.98 B |
0.000 M
|
USA
|
| Market Cap | = | ATNF Stock Price | * | ATNF Shares Outstanding |
| = | $0.89 | * | 4.38 M | |
| = | $3.90 M |